Mitchell Hill

Array ( [id] => 4137515 [patent_doc_number] => 06030609 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Method and composition for treating paramyxovirus' [patent_app_type] => 1 [patent_app_number] => 8/444256 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 8 [patent_no_of_words] => 11266 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030609.pdf [firstpage_image] =>[orig_patent_app_number] => 444256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888537 [patent_doc_number] => 05723585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Method of purifying cardiac hypertrophy factor' [patent_app_type] => 1 [patent_app_number] => 8/443130 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37085 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723585.pdf [firstpage_image] =>[orig_patent_app_number] => 443130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174275 [patent_doc_number] => 06083912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Method for soft tissue augmentation' [patent_app_type] => 1 [patent_app_number] => 8/432517 [patent_app_country] => US [patent_app_date] => 1995-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 3943 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083912.pdf [firstpage_image] =>[orig_patent_app_number] => 432517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828861 [patent_doc_number] => 05739104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Anti-fungal agents' [patent_app_type] => 1 [patent_app_number] => 8/428974 [patent_app_country] => US [patent_app_date] => 1995-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12125 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739104.pdf [firstpage_image] =>[orig_patent_app_number] => 428974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737860 [patent_doc_number] => 05698672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Synthetic calcitonin mimetics' [patent_app_type] => 1 [patent_app_number] => 8/416601 [patent_app_country] => US [patent_app_date] => 1995-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13352 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 781 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698672.pdf [firstpage_image] =>[orig_patent_app_number] => 416601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624193 [patent_doc_number] => 05688992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'O-malonyltryrosyl compounds, O-malonyltryrosyl compound-containing peptides, and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/414520 [patent_app_country] => US [patent_app_date] => 1995-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 13349 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688992.pdf [firstpage_image] =>[orig_patent_app_number] => 414520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807580 [patent_doc_number] => 05854209 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Method for oxygenating tissue having reduced red blood cell flow' [patent_app_type] => 1 [patent_app_number] => 8/409337 [patent_app_country] => US [patent_app_date] => 1995-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10837 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854209.pdf [firstpage_image] =>[orig_patent_app_number] => 409337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3743797 [patent_doc_number] => 05801149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Inhibition of signal transduction molecules' [patent_app_type] => 1 [patent_app_number] => 8/408604 [patent_app_country] => US [patent_app_date] => 1995-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 28686 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801149.pdf [firstpage_image] =>[orig_patent_app_number] => 408604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727988 [patent_doc_number] => 05670478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Pharmaceutical containing N-methylated cyclic undecapeptides' [patent_app_type] => 1 [patent_app_number] => 8/387914 [patent_app_country] => US [patent_app_date] => 1995-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4410 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670478.pdf [firstpage_image] =>[orig_patent_app_number] => 387914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3832859 [patent_doc_number] => 05712247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Use of lactoferrin to modulate and/or neutralize heparin activity' [patent_app_type] => 1 [patent_app_number] => 8/391986 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 9816 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712247.pdf [firstpage_image] =>[orig_patent_app_number] => 391986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1325096 [patent_doc_number] => 06602856 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Antagonists of alpha-melanocyte stimulating hormone and methods based thereon' [patent_app_type] => B1 [patent_app_number] => 08/373151 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 7677 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602856.pdf [firstpage_image] =>[orig_patent_app_number] => 08373151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328702 [patent_doc_number] => 06329499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein' [patent_app_type] => 1 [patent_app_number] => 8/342408 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8846 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329499.pdf [firstpage_image] =>[orig_patent_app_number] => 342408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 479117 [patent_doc_number] => 07223833 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-29 [patent_title] => 'Peptide nucleic acid conjugates' [patent_app_type] => utility [patent_app_number] => 08/319411 [patent_app_country] => US [patent_app_date] => 1994-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 52557 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223833.pdf [firstpage_image] =>[orig_patent_app_number] => 08319411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4066797 [patent_doc_number] => 06008274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Stabilization of copolymers of maleic acid or maleic anhydride and vinyl alkyl ethers' [patent_app_type] => 1 [patent_app_number] => 8/307786 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2022 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008274.pdf [firstpage_image] =>[orig_patent_app_number] => 307786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3666755 [patent_doc_number] => 05668254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'D-2-alkyl-tryptophan and peptides containing same' [patent_app_type] => 1 [patent_app_number] => 8/016862 [patent_app_country] => US [patent_app_date] => 1993-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7165 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668254.pdf [firstpage_image] =>[orig_patent_app_number] => 016862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133334 [patent_doc_number] => 06121239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Peptide substrates for the identification of factor Xa' [patent_app_type] => 1 [patent_app_number] => 7/768710 [patent_app_country] => US [patent_app_date] => 1991-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8408 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121239.pdf [firstpage_image] =>[orig_patent_app_number] => 768710 [rel_patent_id] =>[rel_patent_doc_number] =>)